AbolerIS Pharma (AbolerIS), a clinical-stage biopharmaceutical company committed to improving the lives of people suffering from autoimmune and inflammatory diseases, today announced the appointment of Philippe Alen as Chief Business Officer (CBO).  With over twenty-five years of business development, licensing, M&A, and alliance management experience, Alen will drive Aboleris’ strategic partnerships, financing activities, and corporate growth initiatives. In his new role, Alen w...